INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Bayesian Capital Management, LP's Holding History (CIK: 0001632551)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 37,400 Value ($000) $693 Avg Close — Range —
Q2 2019
Shares 5,402 Value ($000) $430 Avg Close — Range —
Q1 2019
Shares 5,002 Value ($000) $560 Avg Close — Range —
Q3 2017
Shares 4,300 Value ($000) $250 Avg Close — Range —
Q2 2017
Shares 2,500 Value ($000) $303 Avg Close — Range —